These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 3000278)
21. Rehydration in cholera with isotonic sodium chloride cum sodium bicarbonate solution. Chaudhuri RN; Chakravarti RN; Neogy KN; Manji P; Dutta SK J Indian Med Assoc; 1973 Jan; 60(1):1-2. PubMed ID: 4715733 [No Abstract] [Full Text] [Related]
22. Activity of adenosine deaminase in red blood cells of patients suffering from multiple sclerosis treated with adrenocorticotropic hormone. Kopff M; Zakrzewska I; Klem J; Puczkowski S; Strzelczyk M; Czernicki J; Chmielewski H Pol J Pharmacol; 1995; 47(6):525-30. PubMed ID: 8868375 [TBL] [Abstract][Full Text] [Related]
23. Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial. Santoso JT; Lucci JA; Coleman RL; Schafer I; Hannigan EV Cancer Chemother Pharmacol; 2003 Jul; 52(1):13-8. PubMed ID: 12719883 [TBL] [Abstract][Full Text] [Related]
24. Training examiners to administer a quantitative neurological examination for a multicenter clinical trial. Henderson WG; Tourtellotte WW; Potvin AR Arch Phys Med Rehabil; 1975 Jul; 56(7):289-95. PubMed ID: 167673 [TBL] [Abstract][Full Text] [Related]
25. Intravenous methylprednisolone for multiple sclerosis in relapse. Barnes MP; Bateman DE; Cleland PG; Dick DJ; Walls TJ; Newman PK; Saunders M; Tilley PJ J Neurol Neurosurg Psychiatry; 1985 Feb; 48(2):157-9. PubMed ID: 2984332 [TBL] [Abstract][Full Text] [Related]
26. Species differences in the effect of decreased CSF sodium concentration on salt appetite. Denton DA; McKinley MJ; Nelson JF; Osborne P; Simpson J; Tarjan E; Weisinger RS J Physiol (Paris); 1984; 79(6):499-504. PubMed ID: 6100311 [TBL] [Abstract][Full Text] [Related]
27. A new less-invasive and more informative low-dose ACTH test: salivary steroids in response to intramuscular corticotrophin. Contreras LN; Arregger AL; Persi GG; Gonzalez NS; Cardoso EM Clin Endocrinol (Oxf); 2004 Dec; 61(6):675-82. PubMed ID: 15579180 [TBL] [Abstract][Full Text] [Related]
29. Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS. Thompson AJ; Kennard C; Swash M; Summers B; Yuill GM; Shepherd DI; Roche S; Perkin GD; Loizou LA; Ferner R Neurology; 1989 Jul; 39(7):969-71. PubMed ID: 2544829 [TBL] [Abstract][Full Text] [Related]
30. Home intravenous administration of adrenocorticotropic hormone in patients with multiple sclerosis. Molitor RE; Stewart J J Intraven Nurs; 1988; 11(4):249-51. PubMed ID: 2843618 [No Abstract] [Full Text] [Related]
31. Management of worsening multiple sclerosis with mitoxantrone: a review. Fox EJ Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460 [TBL] [Abstract][Full Text] [Related]
32. The effects of topical agents of fluticasone propionate, oxymetazoline, and 3% and 0.9% sodium chloride solutions on mucociliary clearance in the therapy of acute bacterial rhinosinusitis in vivo. Inanli S; Oztürk O; Korkmaz M; Tutkun A; Batman C Laryngoscope; 2002 Feb; 112(2):320-5. PubMed ID: 11889391 [TBL] [Abstract][Full Text] [Related]
33. Current methods of therapy in multiple sclerosis. Sibley WA Mod Treat; 1970 Sep; 7(5):918-29. PubMed ID: 4326377 [No Abstract] [Full Text] [Related]
34. 4-Aminopyridine improves clinical signs in multiple sclerosis. Stefoski D; Davis FA; Faut M; Schauf CL Ann Neurol; 1987 Jan; 21(1):71-7. PubMed ID: 2435223 [TBL] [Abstract][Full Text] [Related]
35. Orally administered 4-aminopyridine improves clinical signs in multiple sclerosis. Davis FA; Stefoski D; Rush J Ann Neurol; 1990 Feb; 27(2):186-92. PubMed ID: 2317014 [TBL] [Abstract][Full Text] [Related]
36. Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial. Majumdar SR; Kjellstrand CM; Tymchak WJ; Hervas-Malo M; Taylor DA; Teo KK Am J Kidney Dis; 2009 Oct; 54(4):602-9. PubMed ID: 19535188 [TBL] [Abstract][Full Text] [Related]
37. Sick building syndrome (SBS) and exposure to water-damaged buildings: time series study, clinical trial and mechanisms. Shoemaker RC; House DE Neurotoxicol Teratol; 2006; 28(5):573-88. PubMed ID: 17010568 [TBL] [Abstract][Full Text] [Related]
38. Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: a randomized, double-blind, placebo-controlled trial. Achiron A; Kishner I; Sarova-Pinhas I; Raz H; Faibel M; Stern Y; Lavie M; Gurevich M; Dolev M; Magalashvili D; Barak Y Arch Neurol; 2004 Oct; 61(10):1515-20. PubMed ID: 15477504 [TBL] [Abstract][Full Text] [Related]
39. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669 [TBL] [Abstract][Full Text] [Related]
40. Effect of early interferon beta-1a therapy on conversion to multiple sclerosis in Iranian patients with a first demyelinating event. Pakdaman H; Sahraian MA; Fallah A; Pakdaman R; Ghareghozli K; Ghafarpour M; Rahimian E; Shirani A Acta Neurol Scand; 2007 Jun; 115(6):429-31. PubMed ID: 17511854 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]